Targeting BAFF and APRIL in systemic lupus erythematosus and other antibody-associated diseases.
about
In this issue: Antibodies in pathogenesis and management of diseases.The Role of B-Cell Maturation Antigen in the Biology and Management of, and as a Potential Therapeutic Target in, Multiple Myeloma.Novel biomarkers for systemic lupus erythematosus.A loop region of BAFF controls B cell survival and regulates recognition by different inhibitors.B Cell Activating Factor, Renal Allograft Antibody-Mediated Rejection, and Long-Term Outcome.
P2860
Targeting BAFF and APRIL in systemic lupus erythematosus and other antibody-associated diseases.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
Targeting BAFF and APRIL in sy ...... antibody-associated diseases.
@en
type
label
Targeting BAFF and APRIL in sy ...... antibody-associated diseases.
@en
prefLabel
Targeting BAFF and APRIL in sy ...... antibody-associated diseases.
@en
P2093
P2860
P1476
Targeting BAFF and APRIL in sy ...... r antibody-associated diseases
@en
P2093
Eileen Samy
Henry Hess
Pascal Schneider
Stephen Wax
P2860
P356
10.1080/08830185.2016.1276903
P577
2017-01-01T00:00:00Z